182 MANAGING FACTORS ASSOCIATED WITH PREGNANCY RATE OF HEIFER RECIPIENTS IN LARGE IN VITRO PRODUCED EMBRYO PROGRAMS

2010 ◽  
Vol 22 (1) ◽  
pp. 249
Author(s):  
A. L. A. Scanavez ◽  
F. P. V. Pupim ◽  
G. R. Destro ◽  
L. O. Nunes ◽  
B. G. Alves ◽  
...  
Keyword(s):  
Pregnancy Rate ◽  
Embryo Transfer ◽  
Good Health ◽  
Estradiol Benzoate ◽  
Health Condition ◽  
Sao Paulo ◽  
São Paulo ◽  
Transfer Program ◽  
Good Health Condition

Large programs of in vitro embryo production have been developed in Brazil, but the results are very variable. The objective of this study was to evaluate managing factors that influence pregnancy rate of recipients in a large embryo transfer program. Results of 1104 embryo transfers performed from November 2008 to February 2009 by Transgen Desenvolvimento e Produção Agropecuária Ltda (Uberlˆndia, Minas Gerais, Brazil) were evaluated. Embryos produced in vitro were used: 1/2 Holstein/Gir embryos (n = 139) or 3/4 Holstein/Gir embryos (n = 961) produced from donors 1/2 Holstein/Gir and Gir with Holstein bull semen. Only excellent (grade 1) quality morulae (stage 4), early blastocysts (stage 5), mid- blastocysts (stage 6), or expanded blastocysts (stage 7) were assigned for fresh transfer using the International Embryo Transfer Society guideline for grading embryos. The heifer recipients were 1/2 crossbred Nelore/Simmental, in good health condition, 20 to 30 months of age, 330 to 400 kg of weight, and were maintained on pasture (Tifton) with mineral supplementation ad libitum. The recipients were synchronized as follows: Day 0-intravaginal device with 1.0 g of progesterone (PRIMER®, Tecnopec, São Paulo, SP, Brazil) +2 mg of estradiol benzoate (ESTROGIN®, Farmavet, São Paulo, SP, Brazil); Day 5-150 μg of D-Cloprostenol (PRELOBAN® Intervet, São Paulo, SP, Brazil) + 400IU of eCG (FOLLIGON®, Intervet); Day 8-progesterone device removed; Day 9-1 mg of estradiol benzoate. On Day 17, nonsurgical embryo transfers were performed by a trained technician and synchronization was confirmed by presence of a CL. The effects of the embryo breed, the number of transfers in each recipient (the heifers that failed to get pregnant were used in the next program), and the transfer sequence (i.e. 20 embryo transfers were performed per hour, and approximately 100 per day) on the pregnancy rate was analyzed by logistic regression with the LOGISTIC procedure of SAS (SAS Institute Inc., Cary, NC, USA). The breed of embryo (56.9% for 3/4 Holstein/Gir embryos v. 62.6% for 1/2 Holstein/Gir embryos), the number of transfers in each recipient (first: 56.5% v. second: 61.8% v. third: 55.5% v. ≥fourth: 55.0%), and the transfer sequence during the day of the program (first hour: 57.4% v. second hour: 60.0% v. third hour: 58.1% v. ≥fourth hour: 53.8%) did not influence the pregnancy rate. Within the confines of an extensive embryo transfer program with in vitro produced fresh embryos, a large number of embryo transfers can be executed per day without adversely affecting the pregnancy rate if high-quality embryos are used, the transfers are performed by a trained technician, and recipients are in good health condition and synchronized.

115 FOLLICULAR GROWTH AND BLOOD FLOW OF THE DOMINANT FOLLICLE IN CROSSBRED RECIPIENTS TREATED WITH eCG

2014 ◽  
Vol 26 (1) ◽  
pp. 171
Author(s):  
M. P. Palhao ◽  
N. S. Junior ◽  
C. R. B. Guimarães ◽  
C. A. C. Fernandes ◽  
M. E. O. Ferreira ◽  
...  
Keyword(s):  
Blood Flow ◽  
Pregnancy Rate ◽  
Embryo Transfer ◽  
Sao Paulo ◽  
Ovulation Rate ◽  
São Paulo ◽  
Follicular Growth ◽  
Dominant Follicle ◽  
Follicle Diameter ◽  
Transfer Protocol

This study aimed to explore changes in follicle diameter and blood flow of the dominant follicle (DF), in ovulation and embryo transfer rates, after inclusion of eCG in a protocol for timed embryo transfer. The effect presence or absence of a corpus luteum (CL) at the start of treatment was also included. Crossbred heifers (n = 116, Bos taurus × Bos indicus), with (n = 61) or without (n = 55) CL, were included in the same hormone protocol: Day 0 (D0), insertion of progesterone (P4) device (1.0 g, Sincrogest®, Ouro Fino, São Paulo, Brazil) and 2 mg of oestradiol benzoato (EB, Sincrodiol®, Ouro Fino); D8, removal of P4 device and injection of sodium Cloprostenol (0.250 mg mL–1, Sincrocio®, Ouro Fino). On D8, the animals with and without CL – at the beginning of the protocol – were equally divided into 2 groups (G): G1 – injection of 300 IU (2.0 mL) of eCG (n = 56; Synchro eCG®, Ouro Fino); G2 – 2.0 mL of saline (n = 60). The ovulations were synchronized with 1 mg of EB on D9. From D8 to D11, the diameter of the DF and blood flow in its wall were recorded daily (M5 ultrasound with colour Doppler technology, 7.5-MHz linear array, DPS medical equipment, São Paulo, Brazil). Approximately 100 frames in colour-flow mode, containing entire cross-sections of the DF, were recorded during each examination. The area of the follicular wall with coloured pixels was measured with ImageJ software (Image Processing and Analysis in Java) from the frame with the largest blood flow signal. Before embryo transfer, all heifers were evaluated, and those with good-quality CL received frozen/thawed embryos (ethylene glycol 1.5 mol). Follicle diameter and blood flow area were compared between groups with or without CL before timed embryo transfer protocol and between eCG treatments. The PROC GLM procedure of SAS (version 9.0) and the t-test were used to assess the differences between means. Pregnancy diagnosis was performed on D35. Embryo transfer (ET) rate of the recipients and pregnancy rate were compared between CL or eCG treatments by the chi-squared test. Ovarian status, before hormone protocol, did not change (P > 0.05) the follicular growth of the DF. However, ovulation rate (78.8 v. 65.4%, P < 0.05) and ET rate (78.7 v. 65.4%, P < 0.05) were higher in animals with CL on D0. From D8 to D10, the inclusion of eCG did not affect (P > 0.05) follicular growth and blood flow of the DF. The time effect (P < 0.0001) for follicular blood flow had shown an increase in area of blood flow 24 h after implant removal (7.7 ± 0.7,b 10.2 ± 0.7,a and 12.3 ± 1.0a mm2, for Days 8, 9, and 10, respectively). The eCG did not affect (P > 0.05) the ovulation rate (71.4 and 73.3%, respectively, eCG and no eCG), however, approached an increased (P < 0.06) ET rate (78.8 v. 66.7%). The overall pregnancy rate (51.2%, 43/84) was not affected (P > 0.05) by evaluated variables. In summary, the addition of 300 IU of eCG on D8 of the timed embryo transfer protocol did not change the development of DF but increased the ET rate of the recipients. Biotran, FAPEMIG (project number APQ-1454-12), and CnPQ are acknowledged.

178 USE OF A NEW INTRAVAGINAL DEVICE TO RELEASE PROGESTERONE IN FIXED-TIME EMBRYO TRANSFER EMBRYO RECIPIENTS

2010 ◽  
Vol 22 (1) ◽  
pp. 247
Author(s):  
J. R. V. Pimentel ◽  
P. H. P. Miguez ◽  
A. Kehrle ◽  
E. H. Madureira ◽  
F. A. Braga ◽  
...  
Keyword(s):  
Embryo Transfer ◽  
Body Condition Score ◽  
Block Design ◽  
Fixed Time ◽  
Estradiol Benzoate ◽  
Sao Paulo ◽  
P Value ◽  
São Paulo ◽  
Condition Score ◽  
Intravaginal Device

Progestagen-releasing devices are commonly used for fixed-time artificial insemination and fixed-time embryo transfer (FTET). The aim of this study was to evaluate the efficacy of a new progesterone-releasing intravaginal device made of poly(3-hydroxy)butyrate-valerate copolymer (PHB-V) and poly-ϵ-caprolactone (PCL; Progestar®, Innovare, São Paulo, Brazil) to synchronize crossbredcows and heifers for FTET by determining ovulation, conception, and pregnancy rates. A total of 205 recipients ranging in age from 2 to 8 years (heifers, n = 77; non-suckled cows, n = 69; suckled cows, n = 59) were used on 3 different farms during February, March, and April 2008. The experimental design was a generalized block design (cyclicity, body condition score, postpartum interval, and animal category, i.e. heifers, suckled, or non-suckled cows), with 2 different synchronization treatments for FTET (Progestar® v. Crestar®). Cows were assigned to either Crestar® (norgestomet ear implants; Intervet Schering-Plough, Kenilworth, NJ, USA; n = 103) or Progestar® (PHB-V; n = 102) treatments. All groups were treated with 2 mg of estradiol benzoate i.m. (Innovare) and received the intravaginal or auricular device according to their group (Day 0). Together with P4 device withdrawal (Day 8), all animals received 400 IU of eCG i.m. (Novormon®, Schering-Plough) and 500 μg i.m. of PGF2α, (Sincrocio®, Ouro Fino, Brasil). On Day 9, all cows were treated with 1 mg of estradiol benzoate (Innovare) and the innovulation was performed on Day 17. Embryos were maintained at 37°C during the innovulation period. The percentage of usable recipients (AR) based on the presence of a functional CL on the day of embryo transfer, conception rate (numbers of pregnant recipients of the total number transferred; CR), and pregnancy rate (numbers of pregnant recipients of the total number synchronized; PR) were determined by ultrasonography 23 days after embryo transfer. Data were submitted to ANOVA (PROC GLM, SAS Institute Inc., Cary, NC, USA) and significant differences were considered to have a P-value of <0.05. None of the interactions were significant and there was no effect of treatment on AR (72.8% v. 83.3%), CR (47.9% v. 42.7%), and PR (34.7% v. 35.0%) for Progestar® v. Crestar® groups, respectively. This experiment showed that Progestar® was as efficacious as Crestar® to synchronize crossbred cows and heifers for FTET. FAPESP-Fundação de Amparo à Pesquisa do Estado de São Paulo and CNPq-Conselho Nacional de Desenvolvimento Científico e Tecnológico.

13 USE OF A NEW INTRAVAGINAL DEVICE TO RELEASE PROGESTERONE IN FIXED-TIMED ARTIFICIAL INSEMINATION IN NELLORE COWS (BOS TAURUS INDICUS)

2010 ◽  
Vol 22 (1) ◽  
pp. 164
Author(s):  
F. A. Braga ◽  
F. J. D. Pardo ◽  
P. H. Miguez ◽  
A. Kehrle ◽  
J. R. V. Pimentel ◽  
...  
Keyword(s):  
Pregnancy Rate ◽  
Artificial Insemination ◽  
Body Condition Score ◽  
Estradiol Benzoate ◽  
Sao Paulo ◽  
Pregnancy Rates ◽  
Control Group ◽  
São Paulo ◽  
Effect Of Treatment ◽  
Intravaginal Device

Artificial insemination results can be improved using fixed-timed AI (FTAI). Currently, progesterone release devices, indispensable in FTAI procedures, such as DIB® (Schering-Plough, Kenilworth, NJ, USA), are made of silicone, a nonbiodegradable biocompatible polymer. Recently, biodegradable progesterone (P4)-releasing devices made of poly(3-hydroxy)butyrate-valerate copolymer (PHB-V) and poly-ϵ-caprolactona (PCL) have been developed. To investigate the efficiency on pregnancy rate of FTAI programs using a new intravaginal device made of PHB-V (Progestar®, Innovare, São Paulo, Brazil), 240 Nellore (Bos indicus) cows, between 3 and 8 years of age, were randomly assigned to 2 experiments. In experiment 1, new P4 devices DIB (control group, DIB1; n = 60) were compared with PHB-V (Progestar1; n = 76); in experiment 2, previously used DIB (DIB2; n = 52) and PHB-V (Progestar2; n = 52) devices were compared. All groups were treated with 2 mg of estradiol benzoate i.m. (Innovare) and received the intravaginal device according to group (Day 0). Together with P4 device withdrawal (Day 8) all animals received 300IU of eCG i.m. (Novormon®, Schering-Plough) and 150 μg i.m. of D-cloprostenol (Croniben®, Biogenesis-Bagó, Buenos Aires, Argentina). On Day 9, all cows were treated with 1 mg of estradiol benzoate and the FTAI was performed 30 h later. The data were submitted to ANOVA (PROC GLM of SAS, SAS Institute, Cary, NC, USA), separating as causes of variance the effect of treatment, postpartum period (PPP1-45 until 70 days and PPP2-71 until 90 days), body condition score (BCS4, BCS5, and BCS6 using a 1 to 9 scale), cyclicity (cycling and noncycling) and clean-up bulls (5 bulls nominated with numbers 1 to 5). Significant differences were considered to have P < 0.05. In experiment 1, interactions were not significant, there was no effect of treatment on FTAI (DIB1: 66.7% v. Progestar1: 65.8%) or breeding season pregnancy rates (BSPR; DIB1: 95.0% v. Progestar1: 94.7%) and no effect of other variables on FTAI pregnancy rates (FTAIPR) and BSPR. In experiment 2 there was no effect of treatment on FTAIPR (DIB2: 61.6% v. Progestar2: 55.8%) and BSPR (DIB2: 94.2% v. Progestar2: 88.5%). As ANOVA indicated a significant effect of clean-up bulls on BSPR, Tukey test was used to split it up. A bull of the Progestar2 group had lower performance (41.7%) causing the difference (albeit nonsignificant) on BSPR. This experiment showed that Progestar and DIB had the same efficiency on pregnancy rate and both treatments have the potential to produce FTAIPR >50% and BSPR >90%. Fapesp-Fundação de Amparo à Pesquisa do Estado de São Paulo. CNPq-Conselho Nacional de Desenvolvimento Científico e Tecnológico.

144 PREGNANCY RATES FOLLOWING THE TRANSFER OF IN VITRO FERTILIZED EMBRYOS TO RECIPIENTS ON DAY 6, 7, OR 8 AFTER OESTRUS

2015 ◽  
Vol 27 (1) ◽  
pp. 164
Author(s):  
R. C. Fry ◽  
K. L. Fry ◽  
H. A. McCartney ◽  
W. R. Geddes ◽  
K. Geddes
Keyword(s):  
Pregnancy Rate ◽  
Embryo Transfer ◽  
Pregnancy Rates ◽  
Transfer Program ◽  
In Vitro Production ◽  
Chi Squared ◽  
Grade 3 ◽  
Vitro Production ◽  
Embryo Grade

The aim of this experiment was to investigate the effect of day of synchrony on the pregnancy rate of recipients following the transfer of Day 7 IVF embryos. In addition, the effect of IVF embryo grade and corpus luteum (CL) grade of recipients was determined. A total of 317 cumulus-oocyte complexes collected from 24 dry Brahman cows by TVR were matured, fertilized, and cultured under standard in vitro production procedures (Fry et al. 2003 Theriogenology 59, 446). A total of 89 (44 Grade 1, 43 Grade 2, and 2 Grade 3, IETS classification) in vitro-produced embryos were transferred to parous 4- to 9-year-old dry Brahman cross recipient cattle 7 days after IVF. Two groups of recipient cows were synchronised one day apart with an 8-day CIDR/pg protocol so that oestrous would be concentrated over 3 days with the middle day aligning with the day of IVF (Day 0). Donors that produced a large number of IVF embryos had these divided and transferred into recipients either on Day –1 or Day +1 of synchrony, and those producing less than 4 IVF embryos were transferred into recipients on Day 0. At embryo transfer the ovaries of the recipient were palpated and then scanned by rectal ultrasound and the grade of CL noted (Grade 1 = large distinct CL by palpation, Grade 2 = small distinct CL by palpation, Grade 3 = CL not distinguishable by palpation). Pregnancy was diagnosed by ultrasound scanning on Day 92. Although recipient numbers were low, differences in pregnancy rate between groups were analysed by Chi-squared. Data from the 2 Grade 3 embryos transferred were not included in the analysis (0/2 pregnant). Similar (P > 0.05) pregnancy rates were found when Day 7 IVF embryos were transferred to either Day 6 (17/32 = 53%), Day 7 (9/24 = 38%), or Day 8 (14/31 = 45%) recipients. Furthermore, neither the grade of the embryo (Grade 1: 20/44 = 45%, Grade 2: 20/43 = 47%) nor the grade of recipient CL (Grade 1: 17/45 = 38%, Grade 2: 17/29 = 59%, Grade 3: 6/13 = 46%) effected pregnancy rate (P > 0.05). This experiment demonstrates the flexibility of the IVF embryo to achieve an acceptable pregnancy rate over a range of recipient stages thereby allowing a high usage rate of good-quality recipients in an IVF embryo transfer program.

32 USE OF HORMONE WITH ACTION FOLLICLE-STIMULATING IN OVULATION SYNCHRONIZATION OF CROSSBRED HOLSTEIN-GYR COWS

2010 ◽  
Vol 22 (1) ◽  
pp. 174
Author(s):  
V. A. Nascimento ◽  
G. S. Moura ◽  
M. Dias ◽  
F. A. Oliveira ◽  
A. R. Dias ◽  
...  
Keyword(s):  
Pregnancy Rate ◽  
Body Condition ◽  
Buenos Aires ◽  
Body Condition Score ◽  
Animal Health ◽  
Live Weight ◽  
Fixed Time ◽  
Estradiol Benzoate ◽  
Sao Paulo ◽  
São Paulo

The objective of this study was to evaluate the administration of the follicle-stimulating hormone (FSH-p) or equine chorionic gonadotropin (eCG) in protocols of ovulation synchronization. One hundred forty-nine crossbred Holstein-Gyr cows were used in 2 properties in Minas Gerais and 3 treatments: TControl (n = 49 cows), Day 0: insert of a progesterone device (Primer®, Tecnopec, São Paulo, Brazil) + 2 mg of estradiol benzoate (RIC-BE®); Day 8: removal of Primer + 112 mg of D-cloprostenol (Prolise®, ARSA SRL, Buenos Aires, Argentina) + 1 mg of estradiol benzoate and fixed-time artificial insemination (FTAI) accomplished 44 h after the removal of Primer; TFSH (n = 50 cows), similar to TControl, but on Day 8, 15 mg of FSH-p (Folltropin®, Bioniche Animal Health) was administered; TeCG (n = 50 cows), similar to TControl, with administration on Day 8 of 300 IU of eCG (Novormon®, Syntex SA, Buenos Aires, Argentina). Cows that returned to estrus 14 to 28 days after the FTAI were inseminated once again. For all statistical analysis, we used the program SAS 9.0 (2002; SAS Institute Inc., Cary, NC, USA) at 5% probability. Quantitative variables (live weight, days postpartum, follicular average per cow) were analyzed by variance, and body condition score by Friedman test. The pregnancy rates were submitted to logistic analysis considering the effect of local experimental factors and were analyzed by Spearman correlation among the variables studied and the pregnancy rate. There was no difference (P > 0.05) between treatment for pregnancy rate in FTAI protocols (TControl = 40.82%; TFSH = 38.00%; TeCG = 26.00%), in the first insemination after FTAI (TControl = 56.25%; TFSH = 70.59%; TeCG = 68.42%), and in FTAI plus first insemination after FTAI (TControl = 59.18%; TFSH =62.00%; TeCG = 52.00%), as well as for the estrus repetition (TControl = 55.17%; TFSH = 54.84%; TeCG = 51.35%) and the correlation (P > 0.05) among the pregnancy rate and postpartum period, milk production, body weight and body condition. No effect was observed on the pregnancy rate by the addition of the hormones FSH and eCG in the protocol of ovulation synchronization in crossbred Holstein-Gyr cows; however, reinsemination in the period from 14 to 28 days after FTAI increased the pregnancy rate. CNPq; FAPEMIG; TECNOPEC/São Paulo, Brazil.

28 COMPARISON OF NEW v. PREVIOUSLY USED INTRAVAGINAL DEVICE FOR A PROGESTERONE-BASED TIMED ARTIFICIAL INSEMINATION PROTOCOL IN NELORE (BOS INDICUS) COWS

2010 ◽  
Vol 22 (1) ◽  
pp. 171 ◽  
Author(s):  
J. H. Martins ◽  
M. I. S. Silva ◽  
G. A. Crepaldi ◽  
W. O. Melo ◽  
J. R. S. Torres-Júnior
Keyword(s):  
Pregnancy Rate ◽  
Fixed Time ◽  
Estradiol Benzoate ◽  
Sao Paulo ◽  
Pregnancy Rates ◽  
São Paulo ◽  
Device Removal ◽  
Serum Progesterone ◽  
New Device ◽  
Lactating Cows

The objective of this study was to evaluate the effect of reutilization of intravaginal progesterone devices on pregnancy rate of lactating and nonlactating Nelore cows submitted to fixed-time AI (FTAI). The study used 684 lactating cows (50 to 70 days postpartum) and 361 nonlactating cows (210 to 240 days postpartum). At random stages of the estrous cycle (Day 0), all animals received 2 mg of estradiol benzoate (Estrogin®, Farmavet, São Paulo, Brazil) and the animals of each category (lactating or nonlactating) were allocated in 1 of 2 treatments (new or used). Thus, the 4 groups consisted of lactating/new, lactating/used, nonlactating/new and nonlactating/used. The animals of lactating/new and nonlactating/new groups received a new intravaginal progesterone device (1 g of P4, DIB®, Intervet/Schering-Plough, São Paulo, Brazil) and the cows of lactating/used and nonlactating/used groups received a similar device that had previously been used for 8 days. At the time of P4 device removal (Day 8), the cows were treated with 150 μg of cloprostenol (Preloban®, Intervet/Schering-Plough), 1 mg of estradiol cypionate (ECP®, Pfizer, São Paulo, Brazil), and 300 IU of eCG (Folligon®, Intervet/Schering-Plough). The cows were FTAI on Day 10 (48 to 52 h after device removal). To evaluate the pregnancy rate, an ultrasonographic examination (CHISON 500VET, USP Brasil Eletromedicina, São Paulo, Brazil) was performed 30 days after the FTAI. Data were analyzed using the GENMOD procedure of SAS (SAS Institute, Cary, NC, USA).There was no interaction between treatment and BCS, AI bull, or technician. The pregnancy rates for the groups were 155/300 (51.7%a for lactating/new, 200/384 (52.1%a for lactating/used, 52/154 (33.8%b for nonlactating/new, and 96/207 (46.2%a for nonlactating/used (P = 0.0007). A reduction in pregnancy rate for nonlactating cows occurred when the intravaginal progesterone device was new. Although serum progesterone was not measured in the current trial, it is very likely that this finding might be explained by the high cyclicity rates in beef cows after weaning (210 days postpartum) and by the presence of CL producing additional support of progesterone besides the high P4 from the new device (Baruselli et al. 2004 Anim. Reprod. Sci. 82, 479-486). Many researchers found that greater circulating progesterone concentrations during progesterone implant treatment reduced LH pulsatility, LH follicular receptors, and follicular growth (Ireland and Roche, 1982 J. Reprod. Fertil. 64, 295-302). Furthermore, it seems likely that the presence of smaller-sized ovulatory follicles might contribute to ovulation failures, delayed ovulation, smaller CL area, and decrease in the pregnancy rate (Carvalho et al. 2008 Theriogenology 69, 167-175). In conclusion, lactating cows can be fixed-time inseminated using a new or a previously used DIB® as progesterone source. However, for nonlactating cows, a previously used device may increase pregnancy rates. USP Brasil Eletromedicina, ABS Pecplan and Fazendas Reunidas Rio Bravo.

157 PREGNANCIES AND CALVES AFTER TRANSFER OF IN VITRO-PRODUCED RIVER BUFFALO EMBRYOS AFTER CRYOPRESERVATION

2012 ◽  
Vol 24 (1) ◽  
pp. 190 ◽  
Author(s):  
C. Galli ◽  
R. Duchi ◽  
G. Lazzari ◽  
I. Lagutina ◽  
S. Colleoni ◽  
...  
Keyword(s):  
Pregnancy Rate ◽  
Embryo Transfer ◽  
Prostaglandin F2α ◽  
Gonadotropin Releasing Hormone ◽  
North Coast ◽  
Transfer Program ◽  
Embryo Production ◽  
Releasing Hormone ◽  
In Vitro Embryo Production

In the buffalo, the use of embryo-based biotechnologies for breeding and genetic improvement is still very limited because multiple-ovulation embryo transfer delivers poor results compared with cattle and in vitro embryo production has been used mainly for research purposes. At present, very few reports are available on the transfer of in vitro-produced (IVP) and cryopreserved buffalo embryos. Therefore, the scope of this work was to perform a pilot study to evaluate the viability of frozen-thawed IVP embryos by nonsurgical embryo transfer to recipients in an IVF-embryo transfer program on a farm located on the north coast of Colombia, South America. Buffalo oocytes were recovered at the slaughterhouse from selected donors, matured in vitro for 18 to 20 h in TCM-199 + 10% FCS and 0.5 IU of FSH and 0.5 IU of LH in 5% CO2 at 38.5°C. Four different bulls were used for IVF. After thawing, the semen was separated on a Percoll® gradient and then diluted into SOF-IVF media supplemented with 1 μg mL–1 of heparin and phenylalanine. Presumptive zygotes were cultured in modified SOF supplemented with MEM amino acids for 6 days. Half of the medium was replaced on Day 4 and 6. Developing embryos were selected for freezing on Day 6 and 7. Grade 1 embryos were frozen at the blastocyst stage by slow cooling in 10% glycerol or 1.5 M ethylene glycol. Recipients (heifers n = 79 and uniparous cows n = 17) were synchronized using the CIDR-Synch protocol: on Day 0, gonadotropin-releasing hormone was injected and a CIDR was inserted; on Day 7, prostaglandin F2α was administered; on Day 9, the CIDR was removed; on Day 11, a second injection of gonadotropin-releasing hormone was given; and on Day 17, the embryo was transferred. Each female received, nonsurgically, 1 or 2 embryos in the ipsilateral horn to the functional corpus luteum evaluated by ultrasonography. Pregnancies were evaluated by ultrasonography 30 days after transfer and confirmed by rectal palpation 30 days later. This work was performed in 2 successive experiments during the breeding seasons (January and December, respectively). Overall, 96 recipients were transferred, with 136 embryos obtaining 23 pregnancies (24.2%). There were no statistical differences in pregnancy rate between heifers and cows (25.3 vs 17.7%) and between single (n = 56) and double (n = 39) embryo transfers (21.4 vs 27.5%) by chi square test (P > 0.05). To date, 4 females and 5 males have been born by spontaneous calving (1 stillborn male due to dystocia), 3 pregnancies have been aborted (13%) and 11 pregnancies are ongoing (>7 months). The pregnancy rate obtained in this study in farm conditions (24.2%) is lower than generally obtained with frozen IVP cattle embryos, but it is still a good result in buffalo, where even conventional AI provides a lower success rate as compared with cattle. Finally, this work demonstrates that in vitro embryo production can be successfully implemented in buffalo breeding programs for the exploitation of superior genetics. This work was supported by Regione Lombardia, Por Fers 2007–2013, n°13827741, InnovaB.

189 PREGNANCY RATES IN HEAT-STRESSED DAIRY CATTLE RECEIVING ONE OR TWO IN VITRO-PRODUCED EMBRYOS IN A TIMED EMBRYO TRANSFER PROGRAM

2006 ◽  
Vol 18 (2) ◽  
pp. 202
Author(s):  
M. Franco ◽  
J. Block ◽  
F. D. Jousan ◽  
L. A. de Castro e Paula ◽  
A. M. Brad ◽  
...  
Keyword(s):  
Dairy Cattle ◽  
Pregnancy Rate ◽  
Embryo Transfer ◽  
Fetal Loss ◽  
Pregnancy Rates ◽  
Uterine Horn ◽  
Limiting Factor ◽  
Transfer Program ◽  
In Pregnancy

The objective was to determine whether transfer of two embryos would increase pregnancy rates in heat-stressed dairy recipients receiving an in vitro-produced embryo transferred into the uterine horn ipsilateral to the corpus luteum (CL). Such a treatment would increase the likelihood that the cow receives at least one embryo competent for sustained development. In addition, transfer of two embryos into the ipsilateral uterine horn is likely to increase the amounts of interferon-tau and other embryonic-signaling molecules in the uterus. A total of 32 virgin crossbreed heifers and 26 lactating crossbreed cows were used as timed embryo transfer recipients after being subjected to an ovulation synchronization protocol as follows: GnRH (100 �g) and insertion of previously used progesterone-containing CIDR on Day -10, prostaglandin F2� and CIDR removal on Day -3, and GnRH (100 �g) on Day 0 (day of anticipated ovulation). All recipients had a palpable CL on Day 6 and were randomly selected to receive one (n = 31 recipients) or two (n = 27) embryos on Day 7. At Day 64, the pregnancy rate tended to be higher (P = 0.07) for cows than for heifers. While not significant, heifers that received two embryos tended to have lower pregnancy rates than those that received a single embryo (20% vs. 41%); there was no difference in pregnancy rate in cows (50% for two embryos vs. 57% for one embryo). Pregnancy losses between Day 64 and Day 127 occurred in one group only cows receiving two embryos. In that group, pregnancy rate was 50% at Day 64 but 17% at Day 127. Overall, there was no difference in pregnancy rates at day 127 between cows and heifers, but recipients that received two embryos (17% for cows and 20% for heifers) had lower pregnancy rates (P < 0.03) than recipients that received one embryo (57% for cows and 41% for heifers). Only one animal, a cow, had twin fetuses at day 127. In conclusion, unilateral transfer of two embryos failed to improve pregnancy rates of dairy cattle exposed to heat stress. The fact that fetal loss occurred sooner for heifers than for cows points out the importance of uterine capacity as a limiting factor for maintenance of fetal development of two conceptuses. The suitability of timed embryo transfer was evident from the high pregnancy rates achieved with crossbreed females that received a single embryo. This work was supported by BARD Grant No. US-1551-14, USDA TSTAR Grant No. 2004-14135-14715, Grant No. 2001-12101-11318 from the USDA-IFAFS Program, and CAPES Grant No. 134202-1).

ROLE OF RETINOL AND TOCOPHEROL IN COMBATING SMOG CAUSED ILLNESS AMONG YOUNG WOMAN

2019 ◽  
Author(s):  
Bisma Laeeque
Keyword(s):  
Case Report ◽  
Vitamin A ◽  
Young Woman ◽  
Good Health ◽  
Health Condition ◽  
Strong Positive Correlation ◽  
Daily Diet ◽  
Food And Nutrition ◽  
Good Health Condition

Retinol and Tocopherol are commonly known as fat soluble Vitamin A and D. This research was undertaken with the objective to study Vitamin A and D’s effect in combating smog caused illness among females. This case report highlights diseases caused among young woman of Lahore due to smog. Hypothesis formulated for this study was accepted after testing that intake of daily-recommended amount of Vitamin A and D by females helps them in fighting diseases caused by smog. An intervention based on Food and Nutrition Board’s Recommended Dietary Allowances (RDAs) was planned. After the analysis of data by SPSS and excel, it was indicated that women could fight smog caused diseases better by including Vitamin A and D in their daily diet. It was also found that a strong positive correlation existed between good health condition among females and intake of Vitamin A and D.

Sign in / Sign up

Export Citation Format

Share Document